Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.52 - $14.35 $483,920 - $660,100
-46,000 Reduced 61.25%
29,100 $326,000
Q2 2024

Aug 15, 2024

SELL
$10.58 - $15.61 $70,886 - $104,587
-6,700 Reduced 8.19%
75,100 $807,000
Q1 2024

May 07, 2024

BUY
$14.14 - $19.59 $982,730 - $1.36 Million
69,500 Added 565.04%
81,800 $1.22 Million
Q4 2023

Feb 14, 2024

SELL
$12.85 - $19.15 $57,825 - $86,175
-4,500 Reduced 26.79%
12,300 $222,000
Q3 2023

Nov 14, 2023

SELL
$14.58 - $20.15 $1.92 Million - $2.65 Million
-131,500 Reduced 88.67%
16,800 $291,000
Q2 2023

Aug 11, 2023

BUY
$18.12 - $30.56 $655,944 - $1.11 Million
36,200 Added 32.29%
148,300 $2.69 Million
Q1 2023

May 16, 2023

BUY
$18.73 - $36.26 $528,186 - $1.02 Million
28,200 Added 33.61%
112,100 $2.98 Million
Q4 2022

Feb 14, 2023

SELL
$17.0 - $25.43 $215,900 - $322,961
-12,700 Reduced 13.15%
83,900 $1.62 Million
Q3 2022

Nov 14, 2022

BUY
$7.67 - $24.23 $319,072 - $1.01 Million
41,600 Added 75.64%
96,600 $2.02 Million
Q2 2022

Aug 15, 2022

BUY
$4.11 - $8.75 $226,050 - $481,250
55,000 New
55,000 $441,000
Q1 2022

May 16, 2022

SELL
$7.01 - $14.1 $144,406 - $290,460
-20,600 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$12.27 - $18.26 $252,762 - $376,156
20,600 New
20,600 $278,000

Others Institutions Holding PLRX

About PLIANT THERAPEUTICS, INC.


  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $647M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.